Evidence map›Paper›PMID 38269642›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2024

Improving reporting standards for phenotyping algorithm in biomedical research: 5 fundamental dimensions.

Wei-Qi Wei, Robb Rowley, Angela Wood, Jacqueline MacArthur, Peter J Embi, Spiros Denaxas

Abstract read
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wei-Qi WeiDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.
Robb RowleyNational Human Genome Research Institute, Bethesda, MD 20892, United States.
Angela WoodDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, CB2 1TN, United Kingdom.ORCID 0000-0002-7937-304X
Jacqueline MacArthurBritish Heart Foundation Data Science Center, Health Data Research, London, NW1 2BE, United Kingdom.
Peter J EmbiDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, United States.
Spiros DenaxasBritish Heart Foundation Data Science Center, Health Data Research, London, NW1 2BE, United Kingdom.ORCID 0000-0001-9612-7791

Funding

Vanderbilt Genome-Electronic Records (VGER) ProjectU01HG011181 · NHGRI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DAN M RODEN, Digna R Velez Edwards · 2020 to 2026
$7.0M
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC modelsR01AG069900 · NIA · VANDERBILT UNIVERSITY · PI LI, BINGSHAN, WEI, WEI-QI · 2021 to 2025
$4.0M
Genetics and Triglycerides: opportunities for new approaches to identify therapiesR01HL163854 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FENG, QIPING · 2022 to 2025
$3.1M
Targeting Residual ASCVD Risk by Integrating Genetics and Clinical DataR01HL171809 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Qiping Feng, Wei-Qi Wei · 2024 to 2026
$2.6M
PheMAP: Measured, Automated Profile to Facilitate High Throughput PhenotypingR01GM139891 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WEI, WEI-QI · 2021 to 2024
$1.7M
Pleiotropy of PCSK9 InhibitionR01GM120523 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FENG, QIPING · 2016 to 2020
$1.7M
Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related DementiasR56AG084550 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FENG, QIPING, WEI, WEI-QI · 2024 to 2024
$875k
British Heart FoundationNHGRI NIH HHS U01 HG011181NHLBI NIH HHS R01 HL163854NHLBI NIH HHS R01 HL171809NIA NIH HHS R56 AG084550NIGMS NIH HHS R01 GM120523NIGMS NIH HHS R01 GM139891
6 · The paper itself

Abstract

introductionPhenotyping algorithms enable the interpretation of complex health data and definition of clinically relevant phenotypes; they have become crucial in biomedical research. However, the lack of standardization and transparency inhibits the cross-comparison of findings among different studies, limits large scale meta-analyses, confuses the research community, and prevents the reuse of algorithms, which results in duplication of efforts and the waste of valuable resources. RECOMMENDATIONS: Here, we propose five independent fundamental dimensions of phenotyping algorithms-complexity, performance, efficiency, implementability, and maintenance-through which researchers can describe, measure, and deploy any algorithms efficiently and effectively. These dimensions must be considered in the context of explicit use cases and transparent methods to ensure that they do not reflect unexpected biases or exacerbate inequities.

Indexed as

Biomedical ResearchElectronic Health RecordsAlgorithmsPhenotypeReference StandardsalgorithmEHRphenotypingreportingstandards

Identifiers

PMID38269642
PMCPMC10990558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.